Lisata Therapeutics - 41 Year Stock Price History | LSTA

Historical daily share price chart and data for Lisata Therapeutics since 1984 adjusted for splits and dividends. The latest closing stock price for Lisata Therapeutics as of November 06, 2025 is 2.35.
  • The all-time high Lisata Therapeutics stock closing price was 1000000.00 on November 05, 1984.
  • The Lisata Therapeutics 52-week high stock price is 4.20, which is 78.7% above the current share price.
  • The Lisata Therapeutics 52-week low stock price is 1.87, which is 20.4% below the current share price.
  • The average Lisata Therapeutics stock price for the last 52 weeks is 2.57.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Lisata Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 2.5330 3.5700 3.9000 1.9000 2.3500 -21.14%
2024 3.0034 2.7800 3.7000 2.4700 2.9800 9.16%
2023 3.0236 2.5800 4.4000 1.9600 2.7300 7.91%
2022 7.6280 13.3350 15.4500 2.3900 2.5300 -79.96%
2021 22.1608 21.6000 43.3500 12.4500 12.6240 -41.15%
2020 30.8325 37.8405 52.0500 18.1500 21.4500 -43.03%
2019 46.0137 61.2000 79.7250 30.3000 37.6500 -29.49%
2018 72.8386 55.5000 129.6000 52.3500 53.4000 1.42%
2017 62.6894 46.2120 85.9500 39.9000 52.6500 24.03%
2016 81.9788 162.0000 162.0000 41.5500 42.4500 -73.80%
2015 334.4506 559.5000 625.5000 156.0000 162.0000 -71.35%
2014 900.6280 1165.5000 1212.0000 483.0000 565.5000 -44.72%
2013 979.9384 932.7150 1405.0700 749.7700 1023.0000 14.56%
2012 869.9993 794.7570 1199.6300 464.4080 892.9770 17.46%
2011 1733.7597 2099.1500 3014.0800 674.7930 760.2670 -64.04%
2010 2792.7226 2219.1100 5112.9400 1934.2200 2114.1500 -9.03%
2009 2262.2326 899.6370 3785.8200 680.7260 2324.0600 229.79%
2008 1717.1805 2444.0100 2818.8600 629.7460 704.7160 -64.93%
2007 6738.9816 11245.5000 11995.2000 2009.1900 2009.1900 -82.13%
2006 10295.7442 11995.2000 15143.9000 6747.2800 11245.5000 -6.25%
2005 7644.7551 8996.3700 14994.0000 2249.0900 11995.2000 45.46%
2004 15868.6143 26989.1000 32986.7000 6747.2800 8246.6700 -63.33%
2003 19991.9519 10495.8000 46481.3000 4498.1800 22490.9000 275.00%
2002 34709.7181 65973.4000 101959.0000 5997.5800 5997.5800 -90.36%
2001 69126.5448 65598.6000 121451.0000 29987.9000 62224.9000 -17.00%
2000 307388.1633 318622.0000 623186.0000 65598.6000 74969.8000 -73.33%
1999 177686.4525 131197.0000 384220.0000 103083.0000 281137.0000 114.29%
1998 211331.5421 103083.0000 346735.0000 103083.0000 131197.0000 27.27%
1997 101389.3434 23428.1000 159311.0000 23428.1000 103083.0000 340.00%
1996 49069.5314 37484.9000 168682.0000 18742.4000 23428.1000 -37.50%
1995 507491.3498 374849.0000 960550.0000 37484.9000 37484.9000 -90.00%
1994 676640.6589 1000000.0000 1000000.0000 374849.0000 374849.0000 -62.52%
1993 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1992 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1991 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1990 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1989 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1988 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1987 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1986 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1985 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.020B $0.001B
Lisata Therapeutics Inc. is a clinical-stage biopharmaceutical company. It involved in discovery, development and commercialization of therapies for the treatment of advanced solid tumors and other major diseases. The company's principal product candidate includes LSTA1. Lisata Therapeutics Inc., formerly known as Caladrius Biosciences Inc., is based in BASKING RIDGE, N.J.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $251.679B 18.36
Amgen (AMGN) United States $172.200B 14.63
Gilead Sciences (GILD) United States $152.098B 14.97
Vertex Pharmaceuticals (VRTX) United States $105.801B 27.24
GSK (GSK) United Kingdom $94.907B 10.54
Bristol Myers Squibb (BMY) United States $94.601B 7.08
Regeneron Pharmaceuticals (REGN) United States $68.276B 17.56
Alnylam Pharmaceuticals (ALNY) United States $57.411B 1889.39
CSL (CSLLY) Australia $55.822B 0.00
Argenex SE (ARGX) Netherlands $51.247B 63.63
Insmed (INSM) United States $39.857B 0.00
Novozymes (NVZMY) Denmark $27.845B 0.00
Royalty Pharma (RPRX) United States $23.572B 8.94
BioNTech SE (BNTX) Germany $23.291B 0.00
Biogen (BIIB) United States $22.509B 9.17
Incyte (INCY) United States $20.751B 19.87
Genmab (GNMSF) Denmark $18.831B 16.68
Genmab (GMAB) Denmark $18.742B 17.07
Illumina (ILMN) United States $18.709B 28.08
Roivant Sciences (ROIV) United Kingdom $13.815B 0.00
Exact Sciences (EXAS) United States $13.193B 366.47
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Ascendis Pharma (ASND) Denmark $12.200B 0.00
Guardant Health (GH) United States $11.980B 0.00
Revolution Medicines (RVMD) United States $11.093B 0.00
Exelixis (EXEL) United States $10.824B 17.33
Avidity Biosciences (RNA) United States $10.184B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.144B 18.40
QIAGEN (QGEN) Netherlands $9.792B 18.59
Bio-Techne Corp (TECH) United States $9.332B 34.85
Moderna (MRNA) United States $9.202B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.324B 32.52
Bio-Rad Laboratories (BIO.B) United States $8.323B 29.67
Repligen (RGEN) United States $8.209B 87.86
Halozyme Therapeutics (HALO) United States $8.032B 12.84
Abivax SA (ABVX) France $7.753B 0.00
Metsera (MTSR) United States $7.516B 0.00
Merus (MRUS) Netherlands $7.219B 0.00
Cytokinetics (CYTK) United States $7.083B 0.00
Axsome Therapeutics (AXSM) United States $6.840B 0.00
Nuvalent (NUVL) United States $6.640B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.638B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.478B 0.00
Legend Biotech (LEGN) United States $5.908B 0.00
Krystal Biotech (KRYS) United States $5.796B 29.97
PTC Therapeutics (PTCT) United States $5.762B 7.83
Arrowhead Pharmaceuticals (ARWR) United States $5.573B 0.00
TG Therapeutics (TGTX) United States $5.401B 12.24
Vaxcyte (PCVX) United States $5.278B 0.00
Zealand Pharma (ZLDPF) Denmark $5.256B 5.20
CRISPR Therapeutics AG (CRSP) Switzerland $5.183B 0.00
Alkermes (ALKS) Ireland $5.130B 15.08
Arcellx (ACLX) United States $4.853B 0.00
Protagonist Therapeutics (PTGX) United States $4.845B 111.26
Akero Therapeutics (AKRO) United States $4.323B 0.00
Kymera Therapeutics (KYMR) United States $4.309B 0.00
Viking Therapeutics (VKTX) United States $4.122B 0.00
Immunovant (IMVT) United States $4.114B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.767B 31.90
Ligand Pharmaceuticals (LGND) United States $3.731B 0.00
ADMA Biologics Inc (ADMA) United States $3.668B 26.05
Mirum Pharmaceuticals (MIRM) United States $3.602B 0.00
Belite Bio (BLTE) United States $3.579B 0.00
Praxis Precision Medicines (PRAX) United States $3.485B 0.00
Telix Pharmaceuticals (TLX) Australia $3.483B 0.00
Anbio Biotechnology (NNNN) Germany $3.166B 0.00
Celcuity (CELC) United States $3.165B 0.00
Jyong Biotech (MENS) Taiwan $3.112B 0.00
Ascentage Pharma Group - (AAPG) China $3.071B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.071B 0.00
Disc Medicine (IRON) United States $3.070B 0.00
GRAIL (GRAL) United States $3.051B 0.00
Travere Therapeutics (TVTX) United States $3.017B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.987B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.986B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.901B 86.98
Tarsus Pharmaceuticals (TARS) United States $2.895B 0.00
CG Oncology (CGON) United States $2.894B 0.00
Bavarian Nordic (BVNRY) Denmark $2.857B 13.82
Amicus Therapeutics (FOLD) United States $2.835B 229.75
Zai Lab (ZLAB) China $2.772B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.716B 0.00
Scholar Rock Holding (SRRK) United States $2.691B 0.00
Adaptive Biotechnologies (ADPT) United States $2.679B 0.00
Mineralys Therapeutics (MLYS) United States $2.629B 0.00
IDEAYA Biosciences (IDYA) United States $2.600B 0.00
Apogee Therapeutics (APGE) United States $2.557B 0.00
Apellis Pharmaceuticals (APLS) United States $2.524B 64.36
Cidara Therapeutics (CDTX) United States $2.476B 0.00
Agios Pharmaceuticals (AGIO) United States $2.362B 0.00
Beam Therapeutics (BEAM) United States $2.341B 0.00
Liquidia (LQDA) United States $2.298B 0.00
Denali Therapeutics (DNLI) United States $2.177B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.153B 0.00
Arcus Biosciences (RCUS) United States $2.132B 0.00
ImmunityBio (IBRX) United States $2.118B 0.00
ANI Pharmaceuticals (ANIP) United States $2.010B 18.02
Viridian Therapeutics (VRDN) United States $1.994B 0.00
Mesoblast (MESO) Australia $1.994B 0.00
Twist Bioscience (TWST) United States $1.903B 0.00
Vericel (VCEL) United States $1.877B 310.00
MannKind (MNKD) United States $1.859B 60.60
Certara (CERT) United States $1.858B 34.03
Structure Therapeutics (GPCR) United States $1.855B 0.00
Edgewise Therapeutics (EWTX) United States $1.830B 0.00
Sarepta Therapeutics (SRPT) United States $1.824B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.806B 9.86
Nuvation Bio (NUVB) United States $1.684B 0.00
Janux Therapeutics (JANX) United States $1.655B 0.00
Cogent Biosciences (COGT) United States $1.642B 0.00
Terns Pharmaceuticals (TERN) United States $1.592B 0.00
Celldex Therapeutics (CLDX) United States $1.576B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.552B 0.00
Sionna Therapeutics (SION) United States $1.548B 0.00
Vera Therapeutics (VERA) United States $1.538B 0.00
Alvotech (ALVO) Luxembourg $1.471B 11.09
Intellia Therapeutics (NTLA) United States $1.457B 0.00
UniQure (QURE) Netherlands $1.430B 0.00
AbCellera Biologics (ABCL) Canada $1.402B 0.00
Spyre Therapeutics (SYRE) United States $1.380B 0.00
Zymeworks (ZYME) United States $1.357B 0.00
NeoGenomics (NEO) United States $1.350B 0.00
Immunome (IMNM) United States $1.336B 0.00
Maze Therapeutics (MAZE) United States $1.327B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.312B 0.00
Stoke Therapeutics (STOK) United States $1.303B 34.06
NovoCure (NVCR) Jersey $1.300B 0.00
Trevi Therapeutics (TRVI) United States $1.296B 0.00
Upstream Bio (UPB) United States $1.292B 0.00
Zenas BioPharma (ZBIO) United States $1.286B 0.00
WAVE Life Sciences (WVE) Singapore $1.279B 0.00
Novavax (NVAX) United States $1.249B 3.37
Dynavax Technologies (DVAX) United States $1.208B 35.52
Oric Pharmaceuticals (ORIC) United States $1.202B 0.00
Inhibrx Biosciences (INBX) United States $1.192B 0.00
Precigen (PGEN) United States $1.189B 0.00
CureVac (CVAC) Germany $1.182B 5.49
MiMedx (MDXG) United States $1.179B 20.95
Pharvaris (PHVS) Netherlands $1.136B 0.00
Immatics (IMTX) Germany $1.087B 0.00
Dianthus Therapeutics (DNTH) United States $1.086B 0.00
Fortrea Holdings (FTRE) United States $1.085B 23.43
Oculis Holding AG (OCS) Switzerland $1.012B 0.00
Tango Therapeutics (TNGX) United States $1.011B 0.00
AnaptysBio (ANAB) United States $0.997B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.982B 0.00
Pacira BioSciences (PCRX) United States $0.982B 10.40
Castle Biosciences (CSTL) United States $0.980B 134.28
Sana Biotechnology (SANA) United States $0.970B 0.00
BGM Group (BGM) China $0.961B 0.00
Nurix Therapeutics (NRIX) United States $0.958B 0.00
Rapport Therapeutics (RAPP) United States $0.955B 0.00
Nanobiotix S.A - (NBTX) France $0.947B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.945B 0.00
Kodiak Sciences (KOD) United States $0.942B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.938B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Pharming Group (PHAR) Netherlands $0.903B 0.00
Urogen Pharma (URGN) United States $0.893B 0.00
Arbutus Biopharma (ABUS) United States $0.884B 0.00
Biohaven (BHVN) United States $0.882B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.877B 0.00
CorMedix Inc (CRMD) United States $0.874B 14.88
Kura Oncology (KURA) United States $0.865B 0.00
Septerna (SEPN) United States $0.853B 0.00
Rezolute (RZLT) United States $0.849B 0.00
Palvella Therapeutics (PVLA) United States $0.838B 0.00
Pharming Group (PHGUF) Netherlands $0.805B 0.00
Tyra Biosciences (TYRA) United States $0.790B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.790B 0.00
Bicara Therapeutics (BCAX) United States $0.772B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.760B 34.19
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.759B 0.00
MBX Biosciences (MBX) United States $0.758B 0.00
Vir Biotechnology (VIR) United States $0.750B 0.00
ArriVent BioPharma (AVBP) United States $0.744B 0.00
Astria Therapeutics (ATXS) United States $0.712B 0.00
Gyre Therapeutics (GYRE) United States $0.712B 147.80
GH Research (GHRS) Ireland $0.707B 0.00
Arvinas (ARVN) United States $0.703B 0.00
Geron (GERN) United States $0.695B 0.00
CytomX Therapeutics (CTMX) United States $0.694B 7.52
MeiraGTx Holdings (MGTX) United States $0.690B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.686B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.680B 0.00
Replimune (REPL) United States $0.670B 0.00
Iovance Biotherapeutics (IOVA) United States $0.655B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Ventyx Biosciences (VTYX) United States $0.642B 0.00
Anavex Life Sciences (AVXL) United States $0.628B 0.00
Erasca (ERAS) United States $0.624B 0.00
Myriad Genetics (MYGN) United States $0.613B 0.00
LENZ Therapeutics (LENZ) United States $0.612B 0.00
Prime Medicine (PRME) United States $0.592B 0.00
REGENXBIO (RGNX) United States $0.586B 0.00
Opthea (OPT) Australia $0.583B 0.00
Absci (ABSI) United States $0.570B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.562B 0.00
Prothena (PRTA) Ireland $0.553B 0.00
Niagen Bioscience (NAGE) United States $0.549B 43.00
Olema Pharmaceuticals (OLMA) United States $0.546B 0.00
Verastem (VSTM) United States $0.545B 0.00
Emergent Biosolutions (EBS) United States $0.543B 5.22
Gossamer Bio (GOSS) United States $0.539B 0.00
Compass Therapeutics (CMPX) United States $0.528B 0.00
Eton Pharmaceuticals (ETON) United States $0.516B 0.00
Cytek Biosciences (CTKB) United States $0.510B 0.00
Monopar Therapeutics (MNPR) United States $0.509B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.501B 0.00
NovaBridge Biosciences (NBP) United States $0.491B 0.00
Keros Therapeutics (KROS) United States $0.477B 10.16
Alumis (ALMS) United States $0.476B 0.00
Rapt Therapeutics (RAPT) United States $0.468B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.450B 0.00
Cullinan Therapeutics (CGEM) United States $0.432B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.428B 0.00
Fulcrum Therapeutics (FULC) United States $0.426B 0.00
Neumora Therapeutics (NMRA) United States $0.424B 0.00
DBV Technologies S.A (DBVT) France $0.419B 0.00
Benitec Biopharma (BNTC) United States $0.414B 0.00
Ocugen (OCGN) United States $0.412B 0.00
PureTech Health (PRTC) United States $0.411B 0.00
XOMA Royalty (XOMA) United States $0.403B 0.00
Kamada (KMDA) Israel $0.397B 20.32
Neurogene (NGNE) United States $0.396B 0.00
Inventiva S.A (IVA) France $0.392B 0.00
Northwest Biotherapeutics (NWBO) United States $0.375B 0.00
Design Therapeutics (DSGN) United States $0.373B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.369B 0.00
Bright Minds Biosciences (DRUG) United States $0.367B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.364B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.358B 0.00
AC Immune (ACIU) Switzerland $0.344B 0.00
DiaMedica Therapeutics (DMAC) United States $0.344B 0.00
Aura Biosciences (AURA) United States $0.338B 0.00
Annexon (ANNX) United States $0.331B 0.00
Invivyd (IVVD) United States $0.326B 0.00
EnGene Holdings (ENGN) Canada $0.325B 0.00
Amarin (AMRN) Ireland $0.317B 0.00
Jade Biosciences (JBIO) United States $0.313B 0.00
Tectonic Therapeutic (TECX) United States $0.308B 0.00
Solid Biosciences (SLDB) United States $0.306B 0.00
Alto Neuroscience (ANRO) United States $0.306B 0.00
Kyverna Therapeutics (KYTX) United States $0.301B 0.00
Genelux (GNLX) United States $0.296B 0.00
Contineum Therapeutics (CTNM) United States $0.293B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.286B 0.00
Candel Therapeutics (CADL) United States $0.279B 0.00
BioAge Labs (BIOA) United States $0.269B 0.00
Immuneering (IMRX) United States $0.266B 0.00
Alpha Teknova (TKNO) United States $0.265B 0.00
Entrada Therapeutics (TRDA) United States $0.264B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.262B 0.00
Atea Pharmaceuticals (AVIR) United States $0.257B 0.00
Prima BioMed (IMMP) Australia $0.256B 0.00
Lifecore Biomedical (LFCR) United States $0.254B 0.00
Sagimet Biosciences (SGMT) United States $0.253B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.250B 0.00
Editas Medicine (EDIT) United States $0.250B 0.00
Puma Biotechnology (PBYI) United States $0.249B 5.05
Allogene Therapeutics (ALLO) United States $0.246B 0.00
Crescent Biopharma (CBIO) United States $0.243B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.241B 0.00
Cabaletta Bio (CABA) United States $0.239B 0.00
Voyager Therapeutics (VYGR) United States $0.237B 0.00
Zura Bio (ZURA) United States $0.236B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.235B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.233B 0.00
Adherex Technologies (FENC) United States $0.232B 0.00
Humacyte (HUMA) United States $0.230B 0.00
Aardvark Therapeutics (AARD) United States $0.228B 0.00
Foghorn Therapeutics (FHTX) United States $0.226B 0.00
Tenaya Therapeutics (TNYA) United States $0.225B 0.00
Abeona Therapeutics (ABEO) United States $0.224B 4.74
Black Diamond Therapeutics (BDTX) United States $0.220B 16.83
Adocia (ADOCY) France $0.216B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.215B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.214B 0.00
SELLAS Life Sciences (SLS) United States $0.210B 0.00
Caribou Biosciences (CRBU) United States $0.204B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.204B 0.00
Cartesian Therapeutics (RNAC) United States $0.199B 0.00
GENFIT S.A (GNFT) France $0.195B 0.00
Codexis (CDXS) United States $0.194B 0.00
Nautilus Biotechnology (NAUT) United States $0.191B 0.00
Coherus Oncology (CHRS) United States $0.182B 0.00
Rani Therapeutics Holdings (RANI) United States $0.180B 0.00
MaxCyte (MXCT) United States $0.178B 0.00
C4 Therapeutics (CCCC) United States $0.169B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
Sangamo Therapeutics (SGMO) United States $0.166B 0.00
Molecular Partners AG (MOLN) Switzerland $0.163B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.153B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.151B 0.00
Actuate Therapeutics (ACTU) United States $0.150B 0.00
Elicio Therapeutics (ELTX) United States $0.149B 0.00
Cardiff Oncology (CRDF) United States $0.149B 0.00
PepGen (PEPG) United States $0.149B 0.00
Compugen (CGEN) Israel $0.146B 0.00
BioHarvest Sciences (BHST) Canada $0.145B 0.00
Nuvectis Pharma (NVCT) United States $0.145B 0.00
Vor Biopharma (VOR) $0.143B 0.00
Anika Therapeutics (ANIK) United States $0.142B 0.00
Scilex Holding (SCLX) United States $0.140B 0.00
Entera Bio (ENTX) Israel $0.139B 0.00
Nkarta (NKTX) United States $0.139B 0.00
Spero Therapeutics (SPRO) United States $0.137B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.134B 0.00
Climb Bio (CLYM) United States $0.130B 0.00
Citius Oncology (CTOR) United States $0.129B 0.00
VistaGen Therapeutics (VTGN) United States $0.128B 0.00
Applied Therapeutics (APLT) United States $0.128B 0.00
TuHURA Biosciences (HURA) United States $0.128B 0.00
Forte Biosciences (FBRX) United States $0.128B 0.00
Alector (ALEC) United States $0.127B 0.00
Opus Genetics (IRD) United States $0.127B 0.00
Fate Therapeutics (FATE) United States $0.126B 0.00
Cognition Therapeutics (CGTX) United States $0.124B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.123B 0.00
Alpha Cognition (ACOG) Canada $0.123B 0.00
Seer (SEER) United States $0.122B 0.00
Inovio Pharmaceuticals (INO) United States $0.122B 0.00
Turn Therapeutics (TTRX) United States $0.121B 0.00
Agenus (AGEN) United States $0.118B 0.00
Greenwich LifeSciences (GLSI) United States $0.116B 0.00
EXoZymes (EXOZ) United States $0.113B 0.00
Seres Therapeutics (MCRB) United States $0.111B 0.00
Clene (CLNN) United States $0.109B 0.00
Whitehawk Therapeutics (WHWK) United States $0.106B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.104B 0.00
Instil Bio (TIL) United States $0.104B 0.00
Tevogen Bio Holdings (TVGN) United States $0.103B 0.00
OKYO Pharma (OKYO) $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.101B 0.00
Immix Biopharma (IMMX) United States $0.101B 0.00
Pliant Therapeutics (PLRX) United States $0.101B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.100B 0.00
Starpharma Holdings (SPHRY) Australia $0.100B 0.00
Shattuck Labs (STTK) United States $0.098B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.097B 0.00
Coya Therapeutics (COYA) United States $0.097B 0.00
VTv Therapeutics (VTVT) United States $0.095B 0.00
Estrella Immunopharma (ESLA) United States $0.095B 0.00
Biomea Fusion (BMEA) United States $0.095B 0.00
Ovid Therapeutics (OVID) United States $0.095B 0.00
Connect Biopharma Holdings (CNTB) United States $0.094B 0.00
Kalaris Therapeutics (KLRS) United States $0.094B 0.00
23andMe Holding (MEHCQ) United States $0.092B 0.00
Adverum Biotechnologies (ADVM) United States $0.090B 0.00
Precision BioSciences (DTIL) United States $0.088B 0.00
Quince Therapeutics (QNCX) United States $0.085B 0.00
Artiva Biotherapeutics (ARTV) United States $0.084B 0.00
CAMP4 Therapeutics (CAMP) United States $0.084B 0.00
Sutro Biopharma (STRO) United States $0.083B 0.00
InflaRx (IFRX) Germany $0.083B 0.00
ATyr Pharma (ATYR) United States $0.080B 0.00
BeyondSpring (BYSI) United States $0.079B 0.00
Atara Biotherapeutics (ATRA) United States $0.076B 0.00
Equillium (EQ) United States $0.075B 0.00
Repare Therapeutics (RPTX) Canada $0.074B 0.00
Fortress Biotech (FBIO) United States $0.074B 0.00
Immunic (IMUX) United States $0.071B 0.00
Adagene (ADAG) China $0.071B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.070B 0.00
BioStem Technologies (BSEM) $0.069B 3.60
CervoMed (CRVO) United States $0.068B 0.00
ALX Oncology Holdings (ALXO) United States $0.067B 0.00
XBiotech (XBIT) United States $0.065B 0.00
TScan Therapeutics (TCRX) United States $0.064B 0.00
Spruce Biosciences (SPRB) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.059B 0.00
MiNK Therapeutics (INKT) United States $0.059B 0.00
Adicet Bio (ACET) United States $0.057B 0.00
Cue Biopharma (CUE) United States $0.056B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.054B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
ZIVO Bioscience (ZIVO) United States $0.051B 0.00
Annovis Bio (ANVS) United States $0.050B 0.00
Celularity (CELU) United States $0.049B 0.00
TELA Bio (TELA) United States $0.048B 0.00
Genenta Science S.p.A (GNTA) Italy $0.047B 0.00
INmune Bio (INMB) United States $0.047B 0.00
Skye Bioscience (SKYE) United States $0.047B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.046B 0.00
Aligos Therapeutics (ALGS) United States $0.045B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
PDS Biotechnology (PDSB) United States $0.043B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.042B 0.00
Xilio Therapeutics (XLO) United States $0.042B 0.00
Mersana Therapeutics (MRSN) United States $0.042B 0.00
CalciMedica (CALC) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Hyperion DeFi (HYPD) United States $0.041B 0.00
Medicus Pharma (MDCX) United States $0.041B 0.00
Elutia (ELUT) United States $0.041B 0.00
OnKure Therapeutics (OKUR) United States $0.041B 0.00
X4 Pharmaceuticals (XFOR) United States $0.041B 0.00
Tvardi Therapeutics (TVRD) United States $0.040B 0.00
Radiopharm Theranostics - (RADX) Australia $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
BioAtla (BCAB) United States $0.038B 0.00
RenovoRx (RNXT) United States $0.038B 0.00
Dyadic (DYAI) United States $0.038B 0.00
Rein Therapeutics (RNTX) United States $0.037B 0.00
Generation Bio (GBIO) United States $0.035B 0.00
Alterity Therapeutics - (ATHE) Australia $0.035B 0.00
Quantum Biopharma (QNTM) Canada $0.034B 0.00
SAB Biotherapeutics (SABS) United States $0.033B 0.00
ImageneBio (IMA) United States $0.033B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.032B 0.00
Jasper Therapeutics (JSPR) United States $0.032B 0.00
Intensity Therapeutics (INTS) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Tharimmune (THAR) United States $0.030B 0.00
BioXcel Therapeutics (BTAI) United States $0.030B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.029B 0.00
IBio (IBIO) United States $0.029B 0.00
Q32 Bio (QTTB) United States $0.029B 0.00
Synaptogenix (TAOX) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.028B 0.00
Pluri (PLUR) Israel $0.028B 0.00
Femasys (FEMY) United States $0.027B 0.00
Rallybio (RLYB) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Exicure (XCUR) United States $0.026B 0.00
NextCure (NXTC) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
MetaVia (MTVA) United States $0.024B 0.00
Lexaria Bioscience (LEXX) Canada $0.024B 0.00
Moleculin Biotech (MBRX) United States $0.024B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.023B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Aytu BioPharma (AYTU) United States $0.022B 0.00
Promis Neurosciences (PMN) Canada $0.022B 0.00
Clearside Biomedical (CLSD) United States $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
Cingulate (CING) United States $0.021B 0.00
FibroBiologics (FBLG) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.018B 0.00
Curis (CRIS) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.018B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.017B 0.00
Leap Therapeutics (LPTX) United States $0.017B 0.00
Athira Pharma (ATHA) United States $0.017B 0.00
Longeveron (LGVN) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Palisade Bio (PALI) United States $0.015B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.015B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
BioCardia (BCDA) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
Apollomics (APLM) United States $0.013B 0.00
Dogwood Therapeutics (DWTX) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.011B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Gelteq (GELS) Australia $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Advanced Biomed (ADVB) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Sunshine Biopharma (SBFM) United States $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
IN8bio (INAB) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Bionano Genomics (BNGO) United States $0.007B 0.00
BRIACELL THERAP (BCTX) Canada $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Silo Pharma (SILO) United States $0.007B 0.00
Entero Therapeutics (ENTO) United States $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Black Titan (BTTC) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.004B 0.00
Bone Biologics (BBLG) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
GT Biopharma (GTBP) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00